Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03ONZ
|
|||
Former ID |
DIB008942
|
|||
Drug Name |
MCS-18
|
|||
Synonyms |
Helleborus purpurascens-derived anti-inflammatory analgesic (injection, autoimmune disease), DoNatur
Click to Show/Hide
|
|||
Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 2 | [1] | |
Company |
DoNatur GmbH
|
|||
Structure |
Download2D MOL
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Toll-like receptor 2 (TLR2) | Target Info | Modulator | [1] |
KEGG Pathway | Phagosome | |||
PI3K-Akt signaling pathway | ||||
Toll-like receptor signaling pathway | ||||
Legionellosis | ||||
Leishmaniasis | ||||
Chagas disease (American trypanosomiasis) | ||||
Malaria | ||||
Toxoplasmosis | ||||
Amoebiasis | ||||
Tuberculosis | ||||
Hepatitis B | ||||
Measles | ||||
Herpes simplex infection | ||||
Proteoglycans in cancer | ||||
Inflammatory bowel disease (IBD) | ||||
Rheumatoid arthritis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Panther Pathway | Toll receptor signaling pathway | |||
Pathway Interaction Database | Endogenous TLR signaling | |||
Reactome | Beta defensins | |||
MyD88:Mal cascade initiated on plasma membrane | ||||
Toll Like Receptor TLR6:TLR2 Cascade | ||||
MyD88 deficiency (TLR2/4) | ||||
IRAK4 deficiency (TLR2/4) | ||||
WikiPathways | Toll-like receptor signaling pathway | |||
IL1 and megakaryotyces in obesity | ||||
Human Complement System | ||||
Toll-Like Receptors Cascades | ||||
MyD88:Mal cascade initiated on plasma membrane | ||||
Defensins | ||||
Regulation of toll-like receptor signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | The novel arthritis-drug substance MCS-18 attenuates the antibody production in vivo. Acta Microbiol Immunol Hung. 2008 Mar;55(1):15-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.